GROWTH-HORMONE (GH) SUBSTITUTION FOR ONE-YEAR NORMALIZES ELEVATED GH-BINDING PROTEIN-LEVELS IN GH-DEFICIENT ADULTS SECONDARY TO A REDUCTIONIN BODY-FAT - A PLACEBO-CONTROLLED TRIAL
S. Fisker et al., GROWTH-HORMONE (GH) SUBSTITUTION FOR ONE-YEAR NORMALIZES ELEVATED GH-BINDING PROTEIN-LEVELS IN GH-DEFICIENT ADULTS SECONDARY TO A REDUCTIONIN BODY-FAT - A PLACEBO-CONTROLLED TRIAL, Growth hormone & IGF research, 8(2), 1998, pp. 105-112
The high affinity growth hormone binding protein (GHBP) in human serum
derives from the extracellular domain of the GH receptor. It is well
known that fat mass correlates positively to GHBP levels, but it is un
certain whether GH secretory status influences GHBP levels. Since body
composition is known to change during GH substitution in adult GHD pa
tients, we determined the relation between GHBP and body composition d
uring GH substitution in GHD adults. Twenty-five GHD adults aged 45.0
+/- 1.8 years, were examined before and after 12 months of placebo-con
trolled GH substitution (2 IU/m(2)) in a parallel design. A group of 2
7 healthy age- and gender-matched normal-weight adults provided refere
nce data. The participants underwent anthropometric measurements [body
mass index (BMI), waist/hip ratio (W/H)], computer-tomography (CT-sca
n) of femoral and abdominal regions, dual-energy X-ray absorptiometry
(DEXA-scan), and bioimpedance (BIA), as well as blood sampling. At bas
eline, the GHBP levels were increased compared to controls (1.63 +/- 0
.14 nmol/l vs 1.12 +/- 0.1 nmol/l, P = 0.01). During 12 months of GH s
ubstitution, GHBP levels decreased to the levels of the control subjec
ts. GHBP correlated positively to indices of adiposity in GHD patients
at baseline: intra-abdominal fat (r = 0.54, P = 0.005), subcutaneous
abdominal fat (r = 0.59, P < 0.002), body fat (BIA) (r = 0.41, P = 0.0
44), BMI (r = 0.58, P = 0.002), and total body fat (DEXA scan) (r = 0.
61, P < 0.001). After 12 months of GH substitution, different estimate
s of body fat were significantly decreased in the GH treated group, bu
t the positive relationship between GHBP and these estimates of body f
at was maintained. In multiple linear regression analyses, fasting ins
ulin levels were also a significant determinant of GHBP levels. We con
clude that GHBP levels are increased in GHD patients and decrease to n
ormal levels during 12 months of GH-substitution, Furthermore, GHBP is
predominantly correlated to indices of adiposity also in GHD patients
. (C) 1998 Churchill Livingstone